Digital Personalized Medicine System for Cognitive Disorder Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing and treating cognitive and developmental disorders are inefficient, requiring extensive time, resources, and often result in inaccurate and inconsistent outcomes, with existing treatments not adequately addressing individual patient needs, particularly for conditions like autism and neurodegenerative diseases.
Innovation Solution
A digital personalized medicine system that uses machine learning and AI to assess symptoms through prioritized questions, estimate pharmacokinetics, and adjust therapeutic agent dosing based on individual patient data, including biomarkers, to provide customized treatment plans and monitor treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If prior methods for diagnosing cognitive disorders are used, then diagnosis can be obtained, but the process requires extensive time and resources
Solution Approach 1:
The diagnostic process is segmented into multiple stages: initial screening using digital questionnaires, risk assessment using machine learning classifiers, and confirmatory evaluation. This segmentation allows the system to identify potential cases quickly without requiring all patients to undergo lengthy comprehensive evaluations, thereby reducing overall diagnosis time while maintaining accuracy through progressive filtering.
Solution Approach 2:
The system performs preliminary diagnostic actions through digital questionnaires and automated risk assessment algorithms before clinical evaluation. Machine learning models pre-process patient data to identify high-risk individuals, allowing clinicians to focus resources on cases that require detailed assessment, thus reducing the time burden on both patients and healthcare providers.
2Measurement precision
If prior methods for diagnosing cognitive disorders are used, then diagnosis can be obtained, but the process is resource-intensive
Solution Approach 1:
The system implements self-service diagnostic capabilities where patients complete digital questionnaires and assessments independently at home, eliminating the need for clinicians to administer lengthy tests in-office. Machine learning algorithms automatically analyze responses and generate risk assessments, reducing the need for multiple clinical visits and specialized personnel while maintaining diagnostic quality.
Solution Approach 2:
Manual clinical assessment processes are replaced with automated digital systems. Machine learning classifiers and natural language processing algorithms substitute for human clinicians in initial evaluation stages, automatically analyzing patient responses, medical records, and biomarker data to generate diagnostic recommendations, thereby reducing reliance on extensive human resources.
3Adaptability or versatility
If prior treatment methods are used, then treatment can be provided, but it does not adequately address individual patient needs
Solution Approach 1:
The treatment system dynamically adapts to individual patient characteristics by using machine learning models that process patient-specific data including genetic information, biomarkers, and clinical history. Treatment recommendations are continuously updated based on real-time patient responses and outcomes, allowing the system to personalize therapy while managing complexity through automated data integration and analysis.
Solution Approach 2:
The system personalizes treatment by changing key parameters such as medication dosage, therapy type, and intervention frequency based on individual patient profiles. Machine learning algorithms analyze multiple patient parameters simultaneously and generate optimized treatment regimens tailored to each patient's specific needs, risk factors, and response patterns, thereby achieving high adaptability without requiring complex manual customization.
4Productivity
If digital data is recorded and predetermined treatment plans are suggested, then treatment can be provided, but it may not provide the best treatment for the patient
Solution Approach 1:
The system implements continuous feedback loops where patient responses to treatment are automatically monitored and fed back into machine learning models. Digital questionnaires, biomarker measurements, and clinical outcomes are continuously collected and used to refine treatment recommendations in real-time, ensuring that predetermined plans are dynamically optimized based on actual patient responses rather than static protocols.
Solution Approach 2:
The system performs preliminary treatment optimization using machine learning models that analyze patient data before treatment initiation. Risk assessment algorithms and treatment recommendation engines pre-process patient information to generate personalized treatment plans, allowing clinicians to start with optimized recommendations rather than generic protocols, thereby improving both efficiency and effectiveness from the outset.
Data Source
AI summary
The digital personalized medicine system uses digital data to assess or diagnose symptoms of a subject to provide personalized or more appropriate therapeutic interventions and improved diagnoses. The use of prioritized questions and answers with associated feature importance can be used to assess mental function and allow a subject to be diagnosed with fewer questions, such that diagnosis can be repeated more often and allow the dosage to be adjusted more frequently. Pharmacokinetics of the subject can be estimated based on demographic data and biomarkers or measured, in order to determine a treatment plan for the subject. Also, biomarkers can be used to determine when the patient may be at risk for experiencing undesirable side effects and the treatment plan adjusted accordingly.